Dyne Therapeutics Announces Upsized Public Offering of 18.3 Million Shares at $20.50 per Share
Dyne Therapeutics has priced an upsized public offering for 18.3 million shares at $20.50 each, expected to generate approximately $375.15 million in gross proceeds before fees and expenses.
Tickers: $DYN